Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,775 | -7,301 | -3,595 | -54,206 | -12,508 |
| Depreciation Amortization | 3,311 | 16 | 24 | 581 | 165 |
| Accounts receivable | N/A | N/A | 3,000 | -3,000 | N/A |
| Other Working Capital | -882 | -596 | 3,273 | -4,253 | 965 |
| Other Operating Activity | 3,946 | 1,416 | -1,207 | 52,091 | 6,077 |
| Operating Cash Flow | $-6,399 | $-6,464 | $1,494 | $-8,787 | $-5,301 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 2 | 23 | -9 | -17 | 6 |
| Investing Cash Flow | $2 | $23 | $-9 | $-17 | $6 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 4,500 | 3,100 |
| Debt Repayment | N/A | N/A | N/A | -750 | -100 |
| Common Stock Issued | 16,127 | 1,480 | N/A | 8,970 | N/A |
| Financing Cash Flow | $16,127 | $1,480 | $N/A | $12,720 | $3,000 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -81 |
| Beginning Cash Position | 638 | 5,600 | 4,115 | 132 | 2,507 |
| End Cash Position | 10,368 | 638 | 5,600 | 4,048 | 132 |
| Net Cash Flow | $9,730 | $-4,962 | $1,485 | $3,916 | $-2,375 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,399 | -6,464 | 1,494 | -8,787 | -5,301 |
| Capital Expenditure | N/A | N/A | -9 | -17 | -2 |
| Free Cash Flow | -6,399 | -6,464 | 1,485 | -8,804 | -5,302 |